Generali Asset Management SPA SGR Sells 12,514 Shares of The Cooper Companies, Inc. $COO

Generali Asset Management SPA SGR lessened its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 45.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,887 shares of the medical device company’s stock after selling 12,514 shares during the quarter. Generali Asset Management SPA SGR’s holdings in Cooper Companies were worth $1,021,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of COO. Amundi raised its holdings in Cooper Companies by 6.9% in the first quarter. Amundi now owns 982,828 shares of the medical device company’s stock worth $76,828,000 after buying an additional 63,365 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after acquiring an additional 7,363 shares in the last quarter. Nissay Asset Management Corp Japan ADV increased its position in shares of Cooper Companies by 1.4% during the first quarter. Nissay Asset Management Corp Japan ADV now owns 24,389 shares of the medical device company’s stock valued at $2,057,000 after acquiring an additional 335 shares in the last quarter. Select Equity Group L.P. raised its holdings in Cooper Companies by 185.0% in the 1st quarter. Select Equity Group L.P. now owns 749,050 shares of the medical device company’s stock worth $63,182,000 after acquiring an additional 486,241 shares during the last quarter. Finally, UniSuper Management Pty Ltd lifted its position in Cooper Companies by 14.9% in the 1st quarter. UniSuper Management Pty Ltd now owns 27,919 shares of the medical device company’s stock valued at $2,355,000 after acquiring an additional 3,625 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. Stifel Nicolaus set a $95.00 target price on Cooper Companies and gave the stock a “buy” rating in a report on Friday, December 5th. Morgan Stanley boosted their target price on Cooper Companies from $76.00 to $83.00 and gave the stock an “equal weight” rating in a research report on Monday, December 8th. Barclays restated an “overweight” rating and set a $91.00 price objective on shares of Cooper Companies in a research report on Monday, December 8th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Cooper Companies in a research report on Monday, December 29th. Finally, The Goldman Sachs Group reissued a “sell” rating and set a $71.00 price target (up from $64.00) on shares of Cooper Companies in a report on Monday, December 8th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $90.15.

Insider Activity at Cooper Companies

In other news, Director Maria Rivas bought 1,000 shares of the company’s stock in a transaction that occurred on Thursday, December 18th. The stock was bought at an average price of $82.13 per share, with a total value of $82,130.00. Following the acquisition, the director owned 11,141 shares of the company’s stock, valued at approximately $915,010.33. This represents a 9.86% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Cynthia L. Lucchese purchased 1,784 shares of the firm’s stock in a transaction on Monday, December 22nd. The shares were acquired at an average cost of $84.06 per share, for a total transaction of $149,963.04. Following the completion of the acquisition, the director owned 9,445 shares of the company’s stock, valued at approximately $793,946.70. This trade represents a 23.29% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased a total of 16,014 shares of company stock worth $1,304,416 in the last quarter. 1.98% of the stock is currently owned by insiders.

Cooper Companies Stock Down 1.0%

Shares of COO stock opened at $81.11 on Monday. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $100.24. The stock has a market cap of $15.90 billion, a P/E ratio of 43.14, a P/E/G ratio of 2.32 and a beta of 1.03. The company has a 50 day simple moving average of $76.67 and a two-hundred day simple moving average of $72.87.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.04 EPS. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. On average, research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, September 17th that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the medical device company to reacquire up to 15.4% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s management believes its shares are undervalued.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.